Skip to main content
. 2019 Nov 28;2(Suppl 1):i50–i61. doi: 10.1093/noajnl/vdz049

Table 1.

MPNST cell lines in multiple research publications

Name Original reference(s) Subject has NF1? (gender) Tumor Mutations: NF1 germline based on NM_0000267.3; TP53 specific somatic based on NM_000546.5.
ST-8814 78,79 Yes (male) n.a. NF1 c.910 C>T exon skip
sNF96.2# 26 Yes (male) Primary NF1 c.3683delC
sNF02.2# 80 Yes (male) Metastasis NF1 c.4868A>T
sNF94.3# 81 Yes (female) Metastasis NF1 microdeletion
88-3 82 Yes (female) Primary NF1 c.6952T>C TP53 c.535C>T
88-14 82 Yes, recurrence of NF88-3 Primary, recurrence NF1 c.6952T>C TP53 c.535C>T
90-8 (NF90-8) 83,84 Yes (female) n.a. NF1 microdeletion TP53 c.96 + 1G>A
T265 (T265-2c)* 85 Yes (n.a.) n.a. n.a.
S462 86 Yes (female) n.a. TP53 c.389G>C
S520 86 n.a. n.a. n.a.
STS26T 87,88 No (female) Metastasis TP53 homozygous deletion
S805 89 Yes (n.a.) n.a. n.a.
MPNST-642 90 Yes (male) Primary, recurrence n.a.
MPNST-724 57 No n.a. TP53 c.280delTCA
Hs-Sch-2 91 No (female) Primary TP53 c.818G>A
FU-SFT8611 92 No (male) Metastasis n.a.
FU-SFT8710 92 Yes (female) Primary n.a.
FU-SFT9817 92 No (female) Primary, recurrence n.a.
NMS-2 93 Yes (male) Primary n.a.
NMS-2PC 93 Yes, metastasis of NMS-2 Metastasis n.a.

n.a., not available.

#Available in ATCC repository (atcc.org).

*Recent data suggest that T265 was overgrown by ST88-14 at a very early passage, so T265 data in the literature may not be reliable (Terribas, Gel, Serra, Wallace, Ratner, Largaespada, and others, in preparation).